-
Mashup Score: 0
An artificial intelligence (AI) model trained on fitness tracker data can predict if patients undergoing chemoradiation may need hospitalization, according to a talk at the American Society for Radiation Oncology (ASTRO) annual meeting.
Source: AuntMinnie.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Bradley Monk, MD, FACCOG, FACS, discusses main takeaways from the OUTBACK trial of adjuvant chemotherapy following chemoradiation as primary treatment in patients with locally advanced cervical cancer vs chemoradiation alone.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma - 2 year(s) ago
IntroductionStandard-of-care treatment for patients with newly diagnosed glioblastoma (GBM) after surgery or biopsy includes concurrent chemoradiation followed by maintenance temozolomide (TMZ) with tumor treating fields (TTFields). Preclinical studies suggest TTFields and radiotherapy work synergistically. We report the results of our trial evaluating the safety of TTFields used concurrently…
Source: FrontiersCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal Malignancies - 2 year(s) ago
PURPOSE: Physical activity is associated with decreased hospitalization during cancer treatment. We hypothesize that activity data can help identify and triage high-risk patients with GI cancer undergoing concurrent chemoradiation. MATERIALS AND METHODS: This prospective study randomly assigned patients to activity monitoring versus observation. In the intervention arm, a 20% decrease in daily…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery for HPV-Positive Cancer - 2 year(s) ago
This cohort study evaluates the risk of adverse histopathologic features that meet indications for possible adjuvant radiotherapy or chemoradiotherapy in patients with human papillomavirus–positive oropharynx squamous cell carcinoma undergoing transoral robotic surgery with neck dissection.
Source: jamanetwork.comCategories: Latest Headlines, OtolaryngologyTweet
-
Mashup Score: 4
Written by Daniel E. Lage MD, Msc
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Practice Halt: No Benefit in Cervical Cancer With Adjuvant Chemo - 3 year(s) ago
Adjuvant chemotherapy did not improve survival and was associated with significantly higher toxicity.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 11
A team studying malignant brain tumors has developed a new technique for predicting how individual patients will respond to chemoradiation, a major step forward in efforts to personalize cancer treatment.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Time to treatment initiation and outcomes in high-grade glioma patients in rehabilitation: a retrospective cohort study | CNS Oncology - 4 year(s) ago
Aims: To investigate wait time (WT) for chemoradiation and survival in post-op high-grade glioma (HGG) patients admitted to inpatient rehabilitation compared with those discharged home. Materials &…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NSAIDs During CRT Tied to Improved OS in Patients With HNSCC - 4 year(s) ago
Findings from a cohort study suggest that patients with [HNSCC] who take [NSAIDs] during chemoradiation may achieve an OS advantage.
Source: Oncology Leanring NetworkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
#ASTRO2022 #AI model trained on fitness tracker data can predict if outpatient cancer patients undergoing #chemoradiation may need #hospitalization https://t.co/GX78KX1oUT